THU
Term · Oncology and biomedicine · MLC-T-ONC-008679
A substance being studied in the treatment of some types of cancer. It may help make cancer cells easier to kill with radiation therapy. THU is a type of radiosensitizing agent, a type of multidrug resistance modulator, and a type of cytidine deaminase inhibitor. Also called tetrahydrouridine.
| Identifier | MLC-T-ONC-008679 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | tetrahydrouridine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008679",
"term": "THU",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of some types of cancer. It may help make cancer cells easier to kill with radiation therapy. THU is a type of radiosensitizing agent, a type of multidrug resistance modulator, and a type of cytidine deaminase inhibitor. Also called tetrahydrouridine.",
"expansions": [
"tetrahydrouridine"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/thu/"
}
Record 16,321 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.